Posted on 3/8/18
BioXcel Therapeutics Prices IPO
BRANFORD, Conn., March 08, 2018 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical development company utilizing novel artificial intelligence to identify the next wave . . .
Posted on 3/8/18
Boston Therapeutics Joins the Biotechnology Innovation Organization
LAWRENCE, Mass., March 08, 2018 (GLOBE NEWSWIRE) -- Boston Therapeutics, Inc announces their new participation in MassBIO, an unparalleled network of innovative companies and industry thought . . .
Posted on 3/7/18
Bionik Laboratories Corp. and Curexo Enter Exclusive Distribution Agreement
Bionik Laboratories Corp. (OTCQB: BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions from hospital to home for individuals with neurological and mobility . . .
Posted on 3/7/18
T2 Biosystems Reports Granting of Inducement Award
LEXINGTON, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for . . .
Posted on 3/7/18
Why CVS Health Corporation Sank 14% in February
What happenedCVS Health Corporation (NYSE:CVS) disappointed investors in February, with shares of the retail pharmacy falling 14%, according to data from S&P Global Market Intelligence, as . . .
Posted on 3/6/18
T2 Biosystems Awarded Up To $2 Million by CARB-X
LEXINGTON, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for . . .
Posted on 3/6/18
Celgene Vs. Biogen: Both Are A Steal, But Which One Is Better?
Today, we are going to take a look at Celgene (CELG) and Biogen (BIIB), two comparable biopharmaceutical companies with a market capitalization of $67 billion and . . .
Posted on 3/5/18
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on March . . .
Posted on 3/5/18
Magenta Therapeutics and Heidelberg Pharma Sign Exclusive Multi-Target Research Agreement
CAMBRIDGE, Mass. & LADENBURG, Germany--(BUSINESS WIRE)--Magenta Therapeutics Inc., a biotechnology company developing therapeutics to improve and extend the use of curative bone marrow transplant for more . . .
Posted on 3/5/18
Abiomed Showcases Impella Technology that Enables Heart Recovery at ACC with 25 Presentations
DANVERS, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announces that there are more . . .
Posted on 3/5/18
Nuance and Partners HealthCare Collaborate
BURLINGTON, Mass. and LAS VEGAS, March 05, 2018 (GLOBE NEWSWIRE) -- At HIMSS 2018, Nuance Communications, Inc. (NASDAQ:NUAN), (booth #1143) today announced the signing of a . . .
Posted on 3/5/18
Boston Scientific Acquires Endoscopy Firm EMcision
Boston Scientific (NYSE:BSX) has acquired privately held EMcision Limited for an undisclosed sum. The London- and Montreal-based company's lead product is the Habib EndoHPB probe, a . . .
Posted on 3/2/18
Verastem Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM), focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients, today announced the grant of . . .
Posted on 3/2/18
Akebia Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), . . .
Posted on 3/2/18
Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BURLINGTON, Mass., March 02, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to two new employees for an . . .
Posted on 3/1/18
PEAR Therapeutics to Collaborate with Novartis
BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--PEAR Therapeutics announced today that it has entered into a collaboration with Novartis to develop novel prescription digital therapeutics for schizophrenia and . . .
Posted on 3/1/18
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEWTON, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that the Compensation Committee of Karyopharm’s Board of . . .
Posted on 3/1/18
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BOSTON, March 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline . . .
Posted on 3/1/18
Rubius Therapeutics Closes $100 Million Financing
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Rubius Therapeutics, a biotechnology company pioneering the creation of a new class of extraordinarily active, ready-to-use and life-changing cellular therapies, today announced the successful . . .
Posted on 2/28/18
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine . . .
Posted on 2/28/18
Boston Children's Hospital & Klick Health Announce VR Platform
Boston Children's Hospital and Klick Health today unveiled the HealthVoyager™ medical education and patient experience platform – a Proof of Concept that uses Virtual Reality (VR) . . .
Posted on 2/27/18
Aldeyra Therapeutics Announces Agreement with Johnson & Johnson Innovation
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with inflammatory diseases, today announced . . .
Posted on 2/27/18
IDC MarketScape Names Arcadia a Leader in U.S. Healthcare Clinical and Financial Analytic BPO Services
BURLINGTON, Mass.--(BUSINESS WIRE)--Arcadia.io announced today that IDC named it a Leader in the IDC MarketScape: U.S. Healthcare Clinical and Financial Analytics BPO Services 2017 Vendor Assessment . . .
Posted on 2/27/18
Peak Physical Therapy & Sports Performance Present Women’s Health Workshop at NVNA Cancer Support Center
Sue McCarthy, PT, Director of Women’s Health at Peak Physical Therapy & Sports Performance (left) and Jeanine Jernegen, PT (right) recently presented a workshop on women’s . . .
Posted on 2/27/18
AMAG Reports 2017 Financial Results and Company Update
WALTHAM, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today reported unaudited consolidated financial results for the fourth quarter and full year ended . . .

